The latest news in cancer research, health and policy by Cancer Research UK.
We cover developments in cancer treatments, research into cancer risk and diagnosis as well as the latest cancer science stories. You'll also find analysis and comment on health and cancer policy.
Researchers have found an existing ovarian cancer blood test is far more predictive than originally thought and could potentially pick up other forms of cancer.
The latest ovarian cancer data from the ICBP reveals that while more people are surviving their cancer, there’s still a long way to go.
The Scottish Medicines Consortium (SMC) has accepted 3 new cancer treatments for NHS use in Scotland
A genetic study has found evidence to suggest that women who take statins in the long term could be less likely to develop ovarian cancer.
NICE has made olaparib (Lynparza), a targeted cancer drug, more widely available for people with ovarian cancer on the NHS in England.
A targeted cancer drug has been approved for use on the NHS in Scotland for patients with newly diagnosed ovarian cancer that’s responded to chemotherapy.
A targeted treatment for advanced ovarian cancer has been approved for use on the NHS in England and will be paid for by the Cancer Drugs Fund.
A targeted drug with potential to slow the progress of ovarian cancer has been rejected for use on the NHS in England.
A targeted drug for advanced ovarian cancer will be more widely available for certain patients on the NHS in England.